Impel Pharmaceuticals Inc Asset Turnover Ratio (IMPL), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Impel Pharmaceuticals Inc   (NASDAQ: IMPL)
 

Impel Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Impel Pharmaceuticals Inc asset turnover ratio, the ability of Impel Pharmaceuticals Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.37 in the third quarter (Sep 30 2023), yet the ratio remained below the average, as IMPL's position remain challenging.

Within sector 194 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2023 compared to the preceding quarter from 3146 to 3596.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IMPL Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -68.75 % -64.6 % -58.25 % -11.48 % -14.35 %
Y / Y Revenue Change 55.52 % 127.04 % 148.55 % 767.94 % 3286.81 %
Asset Turnover Ratio (TTM) 0.37 0.26 0.17 0.11 0.07
IMPL's Total Ranking # 3596 # 3146 # 3146 # 3128 # 3128
Seq. Asset Change -22.3 % -31.36 % -29.66 % -16.7 % -11.97 %
Seq. Revenue Change -24.69 % 45.56 % -12.7 % 62.49 % 9.95 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 556
Overall Market # 3596

Asset Turnover Ratio Statistics
High Average Low
3.03 2.42 1.9
(Sep 30 2023)   (Jun 30 2022)




IMPL Company Profile • Back to IMPL Efficiency Comparisons • Compare IMPL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Encision Inc   1.66 $ 6.970  Millions$ 4.209  Millions
Progyny Inc   1.59 $ 1,031.980  Millions$ 650.190  Millions
Champions Oncology Inc   1.56 $ 49.978  Millions$ 31.972  Millions
Vycor Medical Inc   1.56 $ 1.424  Millions$ 0.914  Millions
International Stem Cell Corporation  1.52 $ 8.330  Millions$ 5.476  Millions
Neptune Wellness Solutions Inc   1.51 $ 43.724  Millions$ 28.863  Millions
Chemed Corporation  1.50 $ 2,225.159  Millions$ 1,485.114  Millions
Agile Therapeutics Inc  1.49 $ 19.189  Millions$ 12.850  Millions
Cv Sciences Inc   1.43 $ 15.578  Millions$ 10.932  Millions
Zeo Scientifix Inc   1.41 $ 4.558  Millions$ 3.223  Millions
Henry Schein Inc   1.41 $ 12,693.000  Millions$ 9,033.750  Millions
Zynex inc   1.40 $ 185.842  Millions$ 132.880  Millions
Iridex Corp  1.37 $ 53.117  Millions$ 38.790  Millions
P3 Health Partners Inc   1.33 $ 1,177.727  Millions$ 887.461  Millions
Procyon Corporation  1.32 $ 4.684  Millions$ 3.541  Millions
Option Care Health Inc   1.31 $ 4,204.399  Millions$ 3,201.963  Millions
The Oncology Institute Inc   1.31 $ 309.875  Millions$ 236.153  Millions
Imac Holdings Inc   1.31 $ 8.475  Millions$ 6.458  Millions
Psychemedics Corporation  1.29 $ 21.712  Millions$ 16.782  Millions
Myomo Inc   1.27 $ 17.258  Millions$ 13.562  Millions
Medpace Holdings Inc   1.26 $ 1,781.539  Millions$ 1,410.469  Millions
Viemed Healthcare Inc   1.26 $ 169.777  Millions$ 135.049  Millions
Innovage Holding Corp   1.26 $ 699.354  Millions$ 557.119  Millions
Docgo Inc   1.25 $ 502.051  Millions$ 402.723  Millions
Idexx Laboratories Inc  1.25 $ 3,587.375  Millions$ 2,878.093  Millions
Biolase Inc   1.25 $ 49.382  Millions$ 39.627  Millions
Pressure Biosciences Inc   1.21 $ 2.273  Millions$ 1.875  Millions
Infusystem Holdings Inc  1.21 $ 122.844  Millions$ 101.617  Millions
Cadre Holdings inc   1.20 $ 480.743  Millions$ 400.338  Millions
Opus Genetics Inc   1.19 $ 57.208  Millions$ 48.013  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.